Jeil Pharma Holdings Inc (KRX:002620)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,670.00
-200.00 (-2.54%)
At close: Mar 26, 2025, 3:30 PM KST

Jeil Pharma Holdings Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Operating Revenue
769,968794,714787,256756,633755,330
Upgrade
Other Revenue
9,8559,3295,7085,9356,667
Upgrade
Revenue
779,822804,043792,965762,568761,997
Upgrade
Revenue Growth (YoY)
-3.01%1.40%3.99%0.07%4.13%
Upgrade
Cost of Revenue
573,301589,459612,482582,061570,757
Upgrade
Gross Profit
206,521214,584180,483180,507191,239
Upgrade
Selling, General & Admin
158,410146,364146,465149,808144,028
Upgrade
Research & Development
38,95046,03841,56639,67324,731
Upgrade
Other Operating Expenses
20,7191,363---
Upgrade
Operating Expenses
217,702193,664188,031189,482169,236
Upgrade
Operating Income
-11,18120,920-7,548-8,97522,003
Upgrade
Interest Expense
-8,875-10,672-5,952-3,289-3,194
Upgrade
Interest & Investment Income
2,4564,119508.95256.81179.62
Upgrade
Earnings From Equity Investments
---2,516623.76
Upgrade
Currency Exchange Gain (Loss)
3,019-169.48314.8816.09-722.45
Upgrade
Other Non Operating Income (Expenses)
-7,435-2,492856.19-2,864344.45
Upgrade
EBT Excluding Unusual Items
-22,01611,706-11,820-11,53919,235
Upgrade
Impairment of Goodwill
-44,862-28,604-78,335-17,014-
Upgrade
Gain (Loss) on Sale of Investments
5,9072,9237,12720,87616,146
Upgrade
Gain (Loss) on Sale of Assets
7.970.5323.981,9306.69
Upgrade
Asset Writedown
-662.52-7.42-856.39-382-4,566
Upgrade
Pretax Income
-61,626-13,982-83,861-6,12930,822
Upgrade
Income Tax Expense
4,765-740.82-715.626,74115,881
Upgrade
Earnings From Continuing Operations
-66,391-13,241-83,145-12,87014,941
Upgrade
Net Income to Company
-66,391-13,241-83,145-12,87014,941
Upgrade
Minority Interest in Earnings
15,232-3,0098,5899,388-3,510
Upgrade
Net Income
-51,159-16,250-74,556-3,48211,431
Upgrade
Net Income to Common
-51,159-16,250-74,556-3,48211,431
Upgrade
Shares Outstanding (Basic)
1515151515
Upgrade
Shares Outstanding (Diluted)
1515151515
Upgrade
Shares Change (YoY)
0.03%-0.04%---
Upgrade
EPS (Basic)
-3333.00-1059.00-4856.70-226.85744.64
Upgrade
EPS (Diluted)
-3333.00-1059.00-4857.00-227.00744.64
Upgrade
Free Cash Flow
202.38-10,638-32,717-10,284-33,482
Upgrade
Free Cash Flow Per Share
13.19-693.29-2131.27-669.95-2181.10
Upgrade
Dividend Per Share
--50.00065.00070.000
Upgrade
Dividend Growth
---23.08%-7.14%-
Upgrade
Gross Margin
26.48%26.69%22.76%23.67%25.10%
Upgrade
Operating Margin
-1.43%2.60%-0.95%-1.18%2.89%
Upgrade
Profit Margin
-6.56%-2.02%-9.40%-0.46%1.50%
Upgrade
Free Cash Flow Margin
0.03%-1.32%-4.13%-1.35%-4.39%
Upgrade
EBITDA
2,91833,4763,3578.3130,654
Upgrade
EBITDA Margin
0.37%4.16%0.42%0.00%4.02%
Upgrade
D&A For EBITDA
14,09912,55610,9058,9838,651
Upgrade
EBIT
-11,18120,920-7,548-8,97522,003
Upgrade
EBIT Margin
-1.43%2.60%-0.95%-1.18%2.89%
Upgrade
Effective Tax Rate
----51.52%
Upgrade
Advertising Expenses
9,5975,9296,2288,74210,675
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.